High materiality8/10
RBC Capital on Verastem (VSTM): 'We think shares are undervalued'
Why it may matterVerify against the original reporting
very bullish setup
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
RBC Capital notes Verastem is undervalued with a target of $15, vs a posted price of $4.33.
- RBC sees VSTM undervalued (target $15)
Key facts
- 01
Target: $15
- 02
Posted price: $4.33
- 03
Analyst firm: RBC Capital
- 04
Analyst: Leonid Timashev
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.